TGA Approval

ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial (408212)

ARTG ID

408212

ARTG Name

ELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

June 28, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered - Prescription

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/a14b2da536d2098f33a886680798a55e.pdf

https://medical-cdn.nocode.com/drug_tga/01cbd48b77fa74e2242b0562e15691e6.pdf

Ingredient Name

elranatamab

Empowering clinical research with data-driven insights and AI-powered tools.